Back by popular demand is the annual Open Mic Night, where entrepreneurs share startup stories to help fellow entrepreneurs! Share your startup success story or your invaluable lessons learned from a setback or failure, all in a good faith effort to pay it forward to other founders, startup team members, and entrepreneurs.
Open Mic Night gives you up to three minutes to present your story in front of a panel of expert judges and an engaged audience. Entrepreneurs get an opportunity to practice their presentation skills in front of an unknown audience, get feedback from the panel of experts, and network with attendees. There is ample time to network over pizza and beverages before and after the event. You just never know who you will meet ... really! The event will be held right in the heart Cambridge's innovation hub, Kendall Square, at the Microsoft Technology Center.
To celebrate Boston ENET's 25th year of educating and empowering entrepreneurs, a silver desktop organizer will be awarded to winners in the following categories: 1) Audience Favorite, by vote of the audience, 2) Titanic, a startup that was doomed from start, but gives life saving lessons, 3) Unicorn, a magical surprise, and 4) Rising Phoenix, despite all odds, the startup or team that rose out of the ashes to become a success.
SIGN UP NOW to share your startup story at the annual Boston ENET's Open Mic Night! To pitch at Open Mic Night, please email both Maureen Mansfield at firstname.lastname@example.org and Dr. Nathalie Goletiani email@example.com.
Panelists: Our panelists are drawn from our community of pitch coaches, angel investors, VC investors, entrepreneurs whose startups have scaled, and service providers and business consultants who work in the entrepreneurial space:
Panelist: Mimi Evans, CEO and Founder, Fast Turtle Ventures, http://www.fastturtleventures.com
Mimi Evans is the CEO and Founder of Fast Turtle Ventures, dedicated to helping startups with all aspects of financial fortitude (fundraising, business development, sales and financial organization). In addition, she serves as a 'scout' for Beacon Angels and other angel groups looking to fund top entrepreneurs. Prior to founding Fast Turtle Ventures, she was the Co-Founder and CEO of Salesquest.com, a technology-driven company that provided data to high-tech companies such as Dell, IBM and Microsoft in order to boost their sales, marketing and CRM systems. SalesQuest was acquired by OneSource (now Avention) in 2014. Before founding Salesquest, she worked in sales, marketing and operations at several high-tech companies and other successful start-ups. After a successful exit to OneSource Information Systems, she has focused on helping the entrepreneurial ecosystem in Boston and Cambridge.
Prior to becoming an entrepreneur Mimi served in sales leadership roles for several large technology companies, including IBM, Netscape, and Lotus. In addition to advising clients, entrepreneurs, start-ups, and small businesses Mimi serves as a Judge and Mentor for Mass Challenge 2015. Mimi has extensive experience working with small businesses and startups. This experience provides her with the ability to help them succeed both personally and professionally. She maintains her long time passion for teaching and mentoring entrepreneurs and innovators of all ages and stages, sharing with them the lessons of the ups and downs in creating new products, technologies and services.
Panelist Dr. Mitchell Sanders, Managing Director, Drug and Device Discovery Laboratory (3DL), CMC Group, http://www.cmc-co.net
Dr. Mitch Sanders is a serial entrepreneur with more than 30 years of experience with preclinical animal models and clinical product development in advanced wound care. He is an expert in gene expression and protein biochemistry. Dr. Sanders founded ECI Biotech, a peptide diagnostics company located in Worcester MA. For ECI Biotech, Mitch secured an aggregate of $28M in development funding and grants. In December of 2015 Mitch joined CMC Consulting full time to help expand their newly formed and rapidly growing Global Medical Affairs Division. In April 2015, Mitch was promoted to Managing Director of Drug and Device Discovery Lab (3DL) Services at CMC Group. 3DL, is a state of the art biosafety level II (BSL-2) lab for biochemistry, cell, molecular, and microbiology R&D. 3DL can support clients needs for drug, device and combination product development.
Mitch is an expert in clinical and translational research and is a reviewer for the Wound Healing Society (WHS), CIMIT, MassVentures, MIT, WPI, Tech Sandbox, Piranha Pond, SBANE and the Venture Forum. Mitch has an MS and PhD from WPI in molecular biology and biomedical sciences with 2 postdocs at the Whitehead Institute/ MIT in biochemistry and pathogen genetics. Mitch is also an AALAS certified Laboratory Animal Technician and has over 30 years of expertise in porcine wound healing and surgical models at ECI Biotech, Boston University, and UMASS Medical School.
Panelist: Maia Heymann, Senior Managing Director, Converge Venture Partners, https://convergevp.com, Twitter @MaiaHeymann
Maia has invested in and financed tech companies for over 23 years. She is the Senior Managing Director at Converge Venture Partners, an early stage VC focused on software, internet, and infrastructure tech investments in the northeast. Maia was previously a Managing Director at Shott Capital Management, a $2.7Bn institutional LP investing in VC and PE funds.
Prior to joining Shott, Maia headed BancBoston Ventures, following Bank of America’s acquisition, and she and her team managed the $330M venture capital portfolio. She was previously based in Palo Alto for 10 years where she opened and ran the west coast office for BancBoston Ventures. Maia started her career in Palo Alto as a technology banker providing structured financing solutions for corporate growth, acquisitions, and LBOs. She worked with both public and private tech companies while at Bank of Boston’s High Technology Group in Palo Alto and at Robertson Stephens.
Maia received a B.A., magna cum laude, from Wellesley College, was elected into Phi Beta Kappa.
Panelist: Richard A. Langevin, Principal, Langevin Management Advisors, www.LangevinAdvisors.com
Mr. Langevin heads Langevin Management Advisors, a management consulting firm specializing in optimizing and growing startups as well as established companies. He has 34 years’ experience as a C-level executive and management consultant. He has led the development and implementation of business optimization and growth strategies that delivered quick and significant business results for startup companies and global divisions of multi-billion dollar corporations in a variety of industries. As CEO of software startup Authoriszor he led a $30M IPO and achieved a business valuation of $750M in one year. As General Manager, North America for $4.2B Bull Information Systems, he led their U.S. division from $0.5M to $14M in sales in one year. As acting COO of TMS’ payroll services he developed and led a new business strategy that increased revenues 297% in one year. As a management consultant, he provided the business strategy and helped to secure a $500,000 loan that enabled Blue Selenium Solar to grow 633% in two years. He purchased and led the turnaround of an unprofitable technology company, has been an angel investor in four companies, secured funding for four companies and has led five foreign companies to establish and grow their U.S. business operations.
Richard is on the Advisory Board of Salem State University’s Bertolon School of Business and is involved in entrepreneurship, mentoring and business plan competitions at Salem State University, American University, Boston University, Babson College and Framingham State University. He also works with the Consulate General of Canada in Boston and is a mentor with the Canadian Entrepreneurs in New England’s Mentoring Service (CMS).
Meeting Co-Organizer: Maureen Mansfield, ALM, Chief Contract Officer, MANSFIELD LAW, Twitter: @MaureenManALM
Maureen Mansfield, ALM, is a business development, corporate development, and strategy professional for companies in the private and public sectors. Currently, Maureen is at Mansfield Law where she works with entrepreneurs, inventors, artists, startups, and emerging growth companies. Previously, she cofounded a boot strapped startup that has progressed to a $10 million term sheet agreement. She currently serves as an advisor and mentor for several startups and related entrepreneurial ventures. She is a member of the Executive Board of The Boston Entrepreneurs' Network (Boston ENET), where she leads Alliance Partnerships.
Prior to joining Mansfield Law in 2009, Maureen was a New England Director of Business Development for the award-winning firm Syska & Hennessy, Inc., With S&H, she focused on business development and corporate management strategy for major accounts locally, nationally, and internationally. After helping to bring in its most successful year, Maureen was awarded a seat on the board of directors. Previously, Maureen was a Senior National Accounts Manager at Abbott Laboratories where she focused on contract compliance, increasing revenues, and sales. She initiated and innovated contract management and auditing procedures that resulted in a new nationwide cost center the produced annual savings of over $1 million. She also helped cofound two holiday charities that continue today.
Maureen received two BAs from the University of Iowa, one in Journalism and one in Communication. Maureen also received a Master of Liberal Arts (ALM) in Management with a Concentration in Finance & Control from Harvard University.
Meeting Co-Organizer: Dr. Nathalie Goletiani, M.D., inventor, founder and CEO of POWERFEM Therapeutics; Instructor in Psychiatry at McLean Hospital, Harvard Medical School.
Dr. Goletiani is the Founder and Chief Executive Officer of POWERFEM Therapeutics, a company devoted to novel, networked treatment methods for the care of those suffering from substance abuse and mental illness. Her extensive clinical research into the hormonal effects of nicotine, opioid and cocaine use lead her to new concepts and mechanisms in understanding and treating psychiatric disorders, in particular, disorders experienced by underserved female populations. At Harvard’s McLean Hospital, she was charged with rebuilding and responsible for all the operations of Clinical Research Program, including simultaneously running multiple clinical trials. Based on her patented work, she founded POWERFEM Therapeutics, an independent company devoted to creating new treatments and healthcare solutions. POWERFEM incorporates novel disease concepts and treatments to design cost-effective, integrated mental and substance abuse care solutions across multiple provider networks.
Dr. Goletiani has received numerous national and international awards including most recently the Harvard Livingston Award for the investigation of complex underlying mechanisms in the neurobiology of women. She also received a Harvard University Zinberg Fellowship specifically to support her research on alcohol and drug use disorders. Her research provides a valuable basis for psychotherapeutic public policy decision making on issues of substance abuse and the integrated treatment of mental illness. She has extensively published the results of her research in peer reviewed journals.
Nathalie completed basic and clinic fellowships at the Harvard School of Public Health and at Harvard Medical School. In addition, she has been trained at and conducted medical research at Tbilisi State Medical University, University of Amsterdam and King’s College in London.
Where: Microsoft Technology Center, 255 Main Street /One Cambridge Center, Cambridge, MA. 02142 Phone: (781) 487-6400 The One Cambridge Center GENERAL ENTRANCE is on 255 Main Street, Cambridge, across from the Kendall Square Post Office. Exit Kendall Square T Station to Main Street. Once you exit the station, head down the Marriott side of Main Street going in the direction of Boston/the Longfellow Bridge. The One Cambridge Center entrance is located next to the Boston Properties entrance. Enter through the glass revolving door and proceed to the Microsoft facilities on the second floor. Note: There is also a direct Microsoft entrance across from the rotary at the confluence of Main Street and Broadway. See also: http://www.microsoft.com/en-us/mtc/locations/boston_directions.aspx
PUBLIC TRANSPORTATION: Travel Mass RT 2 East from RT 128 Exit 29A directly to the Alewife MBTA garage. Park at the Alewife Garage ($7.00) on the MBTA subway Red Line. Take the inbound train (the only one available there) for 15 minutes to Kendall / MIT. The entrance to the Microsoft Technology Center is directly across the street from the station.
Admission: General admission is $10. Free to ENET members. Free pizza and soft drinks will be served. Advanced registration is requested but not required.